Kuros Biosciences
Kuros Biosciences is on a mission to discover, develop and deliver innovative biologic technologies.
Kuros Biosciences is on a mission to discover, develop and deliver innovative biologic technologies.
Kuros is a Swiss-headquartered biotech company, listed on the SIX Swiss Stock Exchange since 2016. With additional operations in the Netherlands and the USA, we continue to grow our global team.
To deliver the ideal bone graft, you need the highest quality and quantity of scientific evidence behind it. We believe that this is a key differentiator for Kuros, given the urgent need to advance bone healing.
- Listing on the SIX Swiss Exchange under the symbol KURN
- A commercial & research footprint that spans >20 markets
- 4 teams of internationally renowned clinical and scientific expert advisers
- >25 orthobiologics-related patents
- >400 patients evaluated in Level I, randomized controlled clinical trials
- 10 well-controlled Level I-III clinical trials initiated, including 6 that are complete*
- Published Level 1 evidence in Spine
Website: https://kurosbio.com/
Press Releases: https://kurosbio.com/media-investors/#press-releases
Featured Products
Below is a sample of featured products made by the manufacturer available via Connexion surgical
MagnetOs is a bone graft like no other: thanks to its NeedleGrip™ surface technology, it grows bone even in soft tissues.* This surface technology provides traction for our body’s vitally important ‘pro-healing’ immune cells (M2 macrophages).†‡1,2 This in turn, unlocks previously untapped potential to stimulate stem cells – and form new bone throughout the graft.†§3-6 The growing body of science behind NeedleGrip is called osteoimmunology. But for surgeons and their patients it means one thing: a more predictable fusion.
Leave us your details and interests and the team will be in touch.
